Insulin Lispro Protamine and Insulin Lispro Injectable Suspension

Eli Lilly and Company🇺🇸 United States

FDA Page

Effective Date: Dec 20, 2023
Approval ID: e49f701d-c19f-4cb2-b63f-01a917b33abc
Products: 1 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25 safely and effectively. See full prescribing information for INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25. INSULIN LISPRO PROTAMINE AND INSULIN LISPRO injectable suspension Mix75/25, for subcutaneous use Initial U.S. Approval: 1999 This product is HUMALOG Mix75/25™ (insulin lispro protamine and insulin lispro).

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.